CB-12181, a New Azasugar-Based Matrix Metalloproteinase/Tumor Necrosis Factor- Converting Enzyme Inhibitor, Inhibits Vascular Endothelial Growth Factor-Induced Angiogenesis in Vitro and Retinal Neovascularization in Vivo
Publisher: Bentham Science Publishers
E-ISSN: 1875-5739|6|3|140-147
ISSN: 1567-2026
Source: Current Neurovascular Research, Vol.6, Iss.3, 2009-08, pp. : 140-147
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract